The drug triazavirin, developed by the researchers of the Ural Branch of the Russian Academy of Sciences and the Institute of Chemical Engineering of Ural Federal University, has proved to be an effective remedy against tick-borne viral encephalitis (TBE). Clinical trials conducted by Krasnoyarsk State Medical University led to this conclusion. The results are published...